Vanda Pharmaceuticals Gets FDA Approval for Bipolar, Schizophrenia Treatment
Vanda Pharmaceuticals Gets FDA Approval for Bipolar, Schizophrenia Treatment is drawing significant interest across the industry.
By Kelly Cloonan Vanda Pharmaceuticals received approval from the Food and Drug Administration for its treatment of a type of bipolar disorder as well as schizophrenia. The biopharmaceutical...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Citizens have been shining light on solar power in streets for so long
- Low-cost models surpass Tesla in China; Geely makes bets amid price wars: 7 EV reads
- Rich McKay doesn't anticipate many rules proposals for 2026
- A 15-minute nervous system reset: 5 yoga poses to activate the parasympathetic response
Source: Original →